Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the targeting of end-stage renal disease and chronic kidney disease and manufactures innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidi® and hemodialysis. Its dialysis products include Triferic, Calcitriol Vitamin D Injection, Hemodialysis Concentrates, CitraPure, Dri-Sate, and ancillary products. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Wixom, MI.
Market Cap | 189.853 Million | Shares Outstanding | 93.986 Million | Avg 30-day Volume | 364.496 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.08 |
Price to Revenue | 1.228 | Debt to Equity | 0.6131 | EBITDA | -26.666 Million |
Price to Book Value | 2.2352 | Operating Margin | -45.6935 | Enterprise Value | 38.648 Million |
Current Ratio | 5.43 | EPS Growth | 0.268 | Quick Ratio | 4.913 |
1 Yr BETA | 7.831 | 52-week High/Low | 11.66 / 1.92 | Profit Margin | -49.6648 |
Operating Cash Flow Growth | -8.7583 | Altman Z-Score | -4.5908 | Free Cash Flow to Firm | -22.059 Million |
Earnings Report | 2022-05-16 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
TIMMINS MEGAN C. SEE REMARKS |
|
350,000 | 2021-08-16 | 2 |
|
571,366 | 2021-06-17 | 1 | |
|
178,736 | 2021-06-17 | 1 | |
|
209,831 | 2021-06-17 | 1 | |
|
147,345 | 2021-06-17 | 1 | |
|
157,546 | 2021-06-17 | 1 | |
|
141,458 | 2021-06-17 | 1 | |
ELLISON RUSSELL H SEE REMARKS |
|
200,000 | 2021-05-03 | 0 |
PRATT RAYMOND DENNIS CHIEF DEVELOPMENT OFFICER |
|
112,500 | 2021-05-03 | 0 |
MCGARRY PAUL E PRINCIPAL ACCOUNTING OFFICER |
|
75,000 | 2021-05-03 | 0 |
HOFFMAN MARC L CHIEF MEDICAL OFFICER |
|
150,000 | 2021-05-03 | 0 |
RBI PRIVATE INVESTMENT II, LLC RBI OPPORTUNITIES FUND II, LLC |
|
5,294,077 | 2020-12-21 | 0 |
SKIBSTED RUSSELL SEE REMARKS |
|
0 | 2020-09-15 | 0 |
GUPTA AJAY SR. VP & CHIEF SCIENTIFIC OFF. |
|
574,700 | 2020-04-26 | 0 |
SMITH ANGUS W. CHIEF FINANCIAL OFFICER |
|
168,486 | 2019-11-28 | 0 |
PAUL STUART M CHIEF EXECUTIVE OFFICER |
|
330,056 | 2019-09-04 | 0 |
|
161,278 | 2019-07-29 | 0 | |
|
18,674 | 2019-06-06 | 0 | |
|
31,366 | 2019-06-06 | 0 | |
|
27,710 | 2019-06-06 | 0 | |
KULL DAVID PRINCIPAL ACCOUNTING OFFICER |
|
13,270 | 2019-04-25 | 0 |
|
1,655,759 | 2019-03-25 | 0 | |
RBI PRIVATE INVESTMENT II, LLC |
|
11,622,546 | 2018-10-15 | 0 |
|
5,541,562 | 2018-10-15 | 0 | |
RBI PRIVATE INVESTMENT II, LLC |
|
346,331 | 2018-06-27 | 0 |
|
0 | 2018-03-19 | 0 | |
|
0 | 2018-03-19 | 0 | |
CHIOINI ROBERT L CHAIRMAN, PRESIDENT AND CEO |
|
2,549,907 | 2017-12-15 | 0 |
KLEMA THOMAS E VICE PRESIDENT, CFO |
|
671,492 | 2017-12-15 | 0 |
NORMAN J. RAVICH IRREVOCABLE TRUST NORMAN & SALLY RAVICH FAMILY TRUST |
|
419,150 | 2017-05-19 | 0 |
|
0 | 2017-03-21 | 0 | |
|
12,630 | 2017-03-16 | 0 | |
|
478,659 | 2017-02-20 | 0 | |
|
1,811,252 | 2013-01-28 | 0 | |
KAUSZ ANNAMARIA T VP OF DRUG DEVELOPMENT |
|
0 | 2011-09-23 | 0 |
YOCUM RICHARD C VP - CLIN. DEV. & MED. AFFAIRS |
|
0 | 2010-01-15 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
ROCKWELL MEDICAL INC RMTI | 2022-05-16 16:45:03 UTC | -3.583 | 4.403 | 10000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-16 16:15:03 UTC | -3.583 | 4.403 | 10000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-16 15:45:03 UTC | -3.583 | 4.403 | 10000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-16 15:15:03 UTC | -3.583 | 4.403 | 10000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-16 14:45:03 UTC | -2.3331 | 3.1531 | 10000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-16 14:15:03 UTC | -2.3331 | 3.1531 | 10000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-16 13:45:04 UTC | -2.3331 | 3.1531 | 10000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-16 13:15:03 UTC | -2.3331 | 3.1531 | 15000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-16 12:45:04 UTC | -2.3331 | 3.1531 | 15000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-12 22:15:04 UTC | -2.211 | 3.031 | 350000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-12 21:45:04 UTC | -2.211 | 3.031 | 350000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-12 21:15:03 UTC | -2.211 | 3.031 | 350000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-12 20:45:03 UTC | -2.211 | 3.031 | 350000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-12 20:15:03 UTC | -2.211 | 3.031 | 350000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-12 19:45:03 UTC | -2.211 | 3.031 | 350000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-12 19:15:03 UTC | -2.211 | 3.031 | 350000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-12 18:45:03 UTC | -2.2007 | 3.0207 | 350000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-12 18:15:03 UTC | -2.2007 | 3.0207 | 350000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-12 17:45:03 UTC | -2.2007 | 3.0207 | 350000 |
ROCKWELL MEDICAL INC RMTI | 2022-05-12 17:15:03 UTC | -2.2007 | 3.0207 | 350000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | RMTI | -10000.0 shares, $-4100.0 | 2021-12-31 | N-PORT |